Log in to save to my catalogue

A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derive...

A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derive...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_475600

A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

About this item

Full title

A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

Publisher

England

Journal title

Journal for immunotherapy of cancer, 2022-05, Vol.10 (5), p.e004592

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Adenosine is a metabolite that suppresses antitumor immune response of T and NK cells via extracellular binding to the two subtypes of adenosine-2 receptors, A
ARs. While blockade of the A
ARs subtype effectively rescues lymphocyte activity, with four A
AR antagonists currently in anticancer clinical trials, less is known for the therapeut...

Alternative Titles

Full title

A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_475600

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_475600

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2022-004592

How to access this item